Amylyx Pharmaceuticals listed its stock on Nasdaq and filed reports with the Securities and Exchange Commission.
2 reports, 2 independent
Updated Aug 12
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amylyx Pharmaceuticals listed its stock on Nasdaq and filed reports with the Securities and Exchange Commission.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amylyx Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Candel Therapeutics stock was listed on the Nasdaq exchange on August 18, 2026.
- Iovance Biotherapeutics listed its stock on Nasdaq and received Fast Track designation from the FDA.
- Connect Biopharma listed its stock on the Nasdaq exchange on August 1, 2026.
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.